WIPO Re:Search has come a long way in the eight years since our launch and our commitment to the health of underserved communities has never wavered. Read more about our partnerships and progress in the 2019 BVGH Partnership Hub Annual Report. Read more.
In this publication, BVGH brings to life the WIPO Re:Search portfolio of 155 R&D collaborations focused on improving the prevention, diagnosis, and treatment of some of the world’s most-devastating diseases. The stories show how WIPO Re:Search’s global cross-sector collaborations are driving R&D for neglected infectious diseases.
This publication highlights seven exciting drug development collaborations that are advancing solutions to some of the world’s most pernicious diseases. Each featured collaboration has achieved key R&D milestones and has been advanced and de-risked through WIPO Re:Search.
(June 2019): BVGH President Jennifer Dent sits down with the BIO team at the 2019 BIO International Convention to discuss how the African Access Initiative (AAI) is increasing sustainable access to cancer medicines in Africa.
April 2019 – Africa’s cancer crisis parallels what the USA faced in the 1950s — when cancer invariably meant death. But unlike the past, we now have the tools and technologies to rewrite the cancer narrative. Through collaborative, multi-sector efforts such as AAI, we can reverse cancer mortality patterns on the African continent and bring hope to patients.
March 2019 – WIPO Re:Search is an innovative and impactful public-private partnership model that promotes cross-sector intellectual property sharing and R&D to accelerate tropical disease drug discovery and development. Importantly, WIPO Re:Search also drives progress toward the United Nations Sustainable Development Goals (SDGs). Through case studies, the article illustrates how WIPO Re:Search empowers high-quality tropical disease drug discovery researchers from academic/non-profit organizations and small companies (including scientists in low- and middle-income countries) to leapfrog their R&D programs by accessing pharmaceutical industry resources that may not otherwise be available to them.
January 2019 – Schistosomiasis affects 200+ million people around the world with 700+ million people at risk of contracting the disease. Don’t miss our new publication in The Tropical Medicine and Infectious Disease highlighting the important role WIPO Re:Search and cross-sector partnerships play in eliminating this disease.